Amsterdam

• Beamion PANTUMOR-1: A study to test whether zongertinib helps people with advanced cancers with HER2 alterations Recruiting
  2023-510429-14-00 4 2024-10-22 HER2-mutated or overexpressed/amplified solid tumours
• PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized … Recruiting
  2023-504144-33-01 11 2024-10-17 esophageal cancer
• Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standard of care (SoC) therapy in subjects wi … Recruiting
  2023-509334-19-00 5 2024-10-17 gastro-enteropancreatic neuroendocrine tumors (GEP-NETs)
• DOSAgE study: A multicenter randomized phase III trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older patients Recruiting
  2023-506115-17-00 5 2024-10-14 Metastatic Colorectal Cancer
• Can we Save the rectum by watchful waiting or transanal surgery following short- or long-course radioTherapy and Additional local oR systemi … Recruiting
  2024-514620-17-00 4 2024-10-14 Patients with early-stage rectal cancer (defined as early rectal cance
• Precision psychiatry: Anti-inflammatory medication in Immuno-metabolic depression Recruiting
  2024-513907-15-01 5 2024-10-11 Major Depressive Disorder
• TAP-TAU Recruiting
  2023-505430-10-00 10 2024-10-10 Mild cognitive impairment and dementia
• A Phase 2a, dose-finding, randomized, double-blinded, placebo-controlled study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safet … Recruiting
  2023-509613-37-01 9 2024-10-08 Alzheimer's Disease
• Uptake and biodistribution of 89Zirconium-labeled ipilimumab in ipilimumab treated patients with metastatic melanoma Recruiting
  2024-516547-11-00 4 2024-10-08 skincancer
• Rituximab-induced remission in CIDP (ReCIX study) Recruiting
  2024-512506-25-00 5 2024-10-07 Chronic inflammatory demyelinating polyneuropathy (CIDP)
• A clinical imaging Study of the changes in [18F]F-AraG uptake following Radiotherapy in Non-small cell lung cancer. Recruiting
  2024-517960-45-00 9 2024-10-02 Melanoma
• An extension study for patients previously enrolled in studies with pelabresib Recruiting
  2023-508950-24-00 5 2024-10-01 Myelofibrosis
• Tranexamic acid to prevent OpeRation in Chronic subdural Hematoma (TORCH) Recruiting
  2024-514927-40-02 11 2024-10-01 Chronic Subdural Hematoma
• A study in people with obesity to test the effects of different doses of BI 456906 compared with semaglutide on glucagon receptor activity i … Recruiting
  2024-515417-17-00 3 2024-10-01 No targeted indication. Male and female subjects with obesity.
• A lower dose olaparib, combined with a drug which inhibits olaparib degradation, to increase tolerability and decrease the price of the trea … Recruiting
  2024-516414-38-00 11 2024-10-01 Cancer
• Efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled clinical trial. (EDIT-CAS) Recruiting
  2023-507782-25-00 10 2024-09-27 Coronary vasomotor dysfunction (spasm)
• IcoSApent ethyL to slow down aortic VAlve stenosis proGrEssion (SALVAGE) Recruiting
  2024-517342-33-01 4 2024-09-27 Aortic valve stenosis
• A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of iptacopan in patients w … Recruiting
  2023-507064-39-00 5 2024-09-26 generalized Myasthenia Gravis
• A clinical trial to learn about the safety and effects of STX-241, a new oral anticancer drug for the treatment of patients with advanced lu … Recruiting
  2023-510203-21-00 7 2024-09-24 locally advanced or metastatic non-small cell lung cancer (NSCLC) resi
• [68Ga]Ga-PentixaFor positron emission tomography for improved risk and disease assessment in myeloma Recruiting
  2022-501811-14-00 9 2024-09-20 Multiple Myeloma
• STOP-IMH Recruiting
  2024-517783-37-00 6 2024-09-20 ST elevation myocardial infarction (STEMI)
• PREOPANC-5 Recruiting
  2023-508707-20-00 9 2024-09-19 Borderline resectable pancreatic cancer (BRPC)
• Personalized dosing of FOLFIRINOX in pancreatic cancer patients: a phase-2 pharmacokinetic, safety and feasibility trial Recruiting
  2024-510576-21-00 4 2024-09-18 Pancreatic cancer
• Dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: the effect on comorbid eosinophilic otitis media Recruiting
  2023-508068-31-00 6 2024-09-11 chronic rhinosinusitis with nasal polyps

Showing 433–456 of 1,112 trials